Cambiar Investors’s Pfizer PFE Stock Holding History

Cambiar Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-930,718	Closed	-$28.9M	–	155
2020 Q2	$28.9M	Sell	930,718 -336,016	-27%	-$11.4M	1.32%	32
2020 Q1	$39.2M	Buy	+1,266,734	New	+$43.2M	1.97%	14

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cambiar Investors's PFE Position: Q3 2020 in Review

Cambiar Investors sold out of Pfizer (PFE) in Q3 2020, closing a stake of 930,718 shares — an estimated $28.9M sold.

Cambiar Investors first reported a position in PFE in Q1 2020 and held it in 2 quarters. The position peaked at $39.2M in Q1 2020. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Cambiar Investors reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
Cambiar Investors sold 930,718 Pfizer shares in Q3 2020, an estimated $28.9M.
Cambiar Investors first reported a position in Pfizer in Q1 2020 and held it in 2 quarters.
Cambiar Investors's Pfizer position peaked at $39.2M in Q1 2020.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Cambiar Investors's 13F filing for Q3 2020, filed 21 Oct 2020.